Obesity and renal hemodynamics.
暂无分享,去创建一个
J. J. Homan van der Heide | P. D. de Jong | G. Navis | J. Krikken | R. Bosma | J. Heide | J. Krikken | Jan A. Krikken | J. J. H. V. D. Heide | P. E. D. Jong | Gerjan Navis
[1] S. T. Boyd,et al. Update on Rimonabant—A Selective Cannabinoid CB1 Antagonist , 2006, The Annals of pharmacotherapy.
[2] T. Srivastava. Nondiabetic consequences of obesity on kidney , 2006, Pediatric Nephrology.
[3] N. Hollenberg,et al. Body Mass Index and Angiotensin-Dependent Control of the Renal Circulation in Healthy Humans , 2005, Hypertension.
[4] G. Navis,et al. Predictive Performance of Renal Function Equations in Renal Transplant Recipients: An Analysis of Patient Factors in Bias , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] M. Cirillo,et al. Relationship of gender, age, and body mass index to errors in predicted kidney function. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[6] A. Mark,et al. Role of selective leptin resistance in diet-induced obesity hypertension. , 2005, Diabetes.
[7] A. Rodríguez,et al. Morbid Obesity, Hypertensive Disease and the Renin-Angiotensin-Aldosterone Axis , 2005, Obesity surgery.
[8] M. Wofford,et al. Pathophysiology and treatment of obesity hypertension. , 2004, Current pharmaceutical design.
[9] R. Gans,et al. Metabolic Syndrome Is Associated with Impaired Long‐term Renal Allograft Function; Not All Component criteria Contribute Equally , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] K. Żwirska-Korczala,et al. Influence of intravenously administered leptin on nitric oxide production, renal hemodynamics and renal function in the rat , 2004, Regulatory Peptides.
[11] M. Ghoneim,et al. WEIGHT GAIN AFTER RENAL TRANSPLANTATION IS A RISK FACTOR FOR PATIENT AND GRAFT OUTCOME , 2004, Transplantation.
[12] A. Aviv,et al. Sodium glomerulopathy: tubuloglomerular feedback and renal injury in African Americans. , 2004, Kidney international.
[13] T. Weinstein,et al. The effects of weight loss on renal function in patients with severe obesity. , 2003, Journal of the American Society of Nephrology : JASN.
[14] G. Navis,et al. A central body fat distribution is related to renal function impairment, even in lean subjects. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] John E. Hall,et al. Obesity-associated hypertension and kidney disease , 2003, Current opinion in nephrology and hypertension.
[16] John E Hall,et al. The kidney, hypertension, and obesity. , 2003, Hypertension.
[17] K. Rahmouni,et al. Leptin and the central neural mechanisms of obesity hypertension. , 2002, Drugs of Today.
[18] H. Hillege,et al. Obesity and target organ damage: the kidney , 2002, International Journal of Obesity.
[19] N. Hollenberg,et al. Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[20] M. Mitsnefes,et al. Body mass index and allograft function in pediatric renal transplantation , 2002, Pediatric Nephrology.
[21] H. Meier‐Kriesche,et al. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. , 2002, Transplantation.
[22] N. Hollenberg. Sodium and the kidney: the non-modulator concept. , 2001, Nephrology, Dialysis and Transplantation.
[23] E. Morales,et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[24] S. Bigler,et al. Functional and structural changes in the kidney in the early stages of obesity. , 2001, Journal of the American Society of Nephrology : JASN.
[25] J. Hall,et al. Obesity hypertension: role of leptin and sympathetic nervous system. , 2001, American journal of hypertension.
[26] F. Berthoux,et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] V. D’Agati,et al. Obesity-related glomerulopathy: an emerging epidemic. , 2001, Kidney international.
[28] S. Engeli,et al. Role of Adipose Tissue for Cardiovascular-Renal Regulation in Health and Disease , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[29] A. Fukamizu,et al. Angiotensinogen, angiotensin II and adipose tissue development , 2000, International Journal of Obesity.
[30] M. Burnier,et al. Proximal Sodium Reabsorption: An Independent Determinant of Blood Pressure Response to Salt , 2000, Hypertension.
[31] R. Pollastro,et al. Glomerular filtration rate in severely overweight normotensive humans. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[32] T. Weinstein,et al. Glomerular hemodynamics in severe obesity. , 2000, American journal of physiology. Renal physiology.
[33] G. Friedman,et al. The effect of body mass index on long-term renal allograft survival. , 1999, Transplantation.
[34] J. Schnermann,et al. The macula densa is worth its salt. , 1999, The Journal of clinical investigation.
[35] J. T. ter Maaten,et al. Insulin's acute effects on glomerular filtration rate correlate with insulin sensitivity whereas insulin's acute effects on proximal tubular sodium reabsorption correlation with salt sensitivity in normal subjects. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[36] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[37] W. Ambrosius,et al. Serum angiotensinogen concentration in relation to gonadal hormones, body size, and genotype in growing young people. , 1998, Hypertension.
[38] A. Distler,et al. Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men , 1998, Journal of hypertension.
[39] N. Hollenberg,et al. Obesity, Salt Intake, and Renal Perfusion in Healthy Humans , 1998 .
[40] G. Jennings,et al. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. , 1997, Circulation.
[41] E. Ferrannini,et al. Renal effects of insulin in man. , 1997, Journal of nephrology.
[42] K. Salmela,et al. Is obesity still a risk factor in renal transplantation? , 1997, Transplant international : official journal of the European Society for Organ Transplantation.
[43] D. Owens,et al. Estimation of glomerular filtration rate in type II (non-insulin dependent) diabetes mellitus patients. , 1997, IMA journal of mathematics applied in medicine and biology.
[44] C. Rotimi,et al. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. , 1997, Circulation.
[45] D. Fliser,et al. Renal function in the elderly: impact of hypertension and cardiac function. , 1997, Kidney international.
[46] D. Jarjoura,et al. Geriatric renal function: estimating glomerular filtration in an ambulatory elderly population. , 1997, Clinical nephrology.
[47] D. de Zeeuw,et al. A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. , 1997, Kidney international.
[48] J. Coresh,et al. Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. , 1997, Journal of the American Society of Nephrology : JASN.
[49] J. Hall,et al. Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. , 1996, Hypertension.
[50] A. Goldberg,et al. Insulin resistance, elevated glomerular filtration fraction, and renal injury. , 1996, Hypertension.
[51] J. Lalouel,et al. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity , 1996, Journal of hypertension.
[52] P. van Paassen,et al. Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension? , 1996, Hypertension.
[53] A. Mimran,et al. Combined renal effects of overweight and hypertension. , 1995, Hypertension.
[54] L. Ruilope,et al. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. , 1995, Nephron.
[55] J. Chapman,et al. Predicting glomerular filtration rate after kidney transplantation. , 1995, Transplantation.
[56] H. Parving,et al. Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. , 1995, Kidney international.
[57] S. Corrao,et al. Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[58] J. Chapman,et al. Predicting glomerular filtration rate after simultaneous pancreas and kidney transplantation. , 1995, Clinical transplantation.
[59] R. Schmieder,et al. How should renal hemodynamic data be indexed in obesity? , 1995, Journal of the American Society of Nephrology.
[60] S. K. Park,et al. Renal Function and Hemodynamic Study in Obese Zucker Rats , 1995, The Korean journal of internal medicine.
[61] S. Bianchi,et al. Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. , 1994, Hypertension.
[62] M. Walser,et al. Prediction of glomerular filtration rate from serum creatinine concentration in advanced chronic renal failure. , 1993, Kidney international.
[63] J. Hall,et al. Obesity-induced hypertension. Renal function and systemic hemodynamics. , 1993, Hypertension.
[64] C. Anderson,et al. Glomerular hemodynamic alterations during acute hyperinsulinemia in normal and diabetic rats. , 1992, Kidney international.
[65] B. Kasiske,et al. Renal injury in obese Zucker rats: glomerular hemodynamic alterations and effects of enalapril. , 1992, The American journal of physiology.
[66] V. Campese,et al. Abnormal Renal Hemodynamics in Black Salt-Sensitive Patients With Hypertension , 1991, Hypertension.
[67] S. Heymsfield,et al. Relative expansion of extracellular fluid in obese vs. nonobese women. , 1991, The American journal of physiology.
[68] J. Hall,et al. Chronic intrarenal hyperinsulinemia does not cause hypertension. , 1991, The American journal of physiology.
[69] V. Katch,et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. , 1989, The New England journal of medicine.
[70] L. Landsberg,et al. Obesity, metabolism, and the sympathetic nervous system. , 1989, American journal of hypertension.
[71] W. Deen,et al. "Intact nephrons" as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy. , 1988, The Journal of clinical investigation.
[72] D. Salazar,et al. Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. , 1988, The American journal of medicine.
[73] A. Fogo,et al. Serial micropuncture analysis of single nephron function in subtotal renal ablation. , 1988, Kidney international.
[74] E. Frohlich,et al. Renal Haemodynamic Studies in Obesity Hypertension , 1987, Journal of hypertension.
[75] O. Iimura,et al. The pathophysiological role of water-sodium balance and renal dopaminergic activity in overweight patients with essential hypertension. , 1987, Journal of clinical hypertension.
[76] N. Hollenberg,et al. Abnormal Renal Sodium Handling in Essential Hypertension Relation to Failure of Renal and Adrenal Modulation of Responses to Angiotensin II , 1986 .
[77] B. Kasiske,et al. Effects of genetic obesity on renal structure and function in the Zucker rat. , 1985, The Journal of laboratory and clinical medicine.
[78] R. L. Hall,et al. Captopril slows the progression of chronic renal disease in partially nephrectomized rats. , 1985, Toxicology and applied pharmacology.
[79] N W Shock,et al. Longitudinal Studies on the Rate of Decline in Renal Function with Age , 1985, Journal of the American Geriatrics Society.
[80] G. F. Gates,et al. Creatinine clearance estimation from serum creatinine values: an analysis of three mathematical models of glomerular function. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[81] K. Minaker,et al. Influence of Age on Clearance of Insulin in Man , 1982, Diabetes.
[82] B. Brenner,et al. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. , 1981, The American journal of physiology.
[83] G. Koch,et al. Influence of range of renal function and liver disease on predictability of creatinine clearance , 1981, Clinical pharmacology and therapeutics.
[84] J W Rowe,et al. Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man , 1981, Diabetes.
[85] S. Welle,et al. Increased plasma norepinephrine concentrations and metabolic rates following glucose ingestion in man. , 1980, Metabolism: clinical and experimental.
[86] T. Bjornsson. Use of Serum Creatinine Concentrations to Determine Renal Function1 , 1979, Clinical pharmacokinetics.
[87] Roger W. Jelliffe,et al. Creatinine Clearance: Bedside Estimate , 1973 .
[88] S B Lucas,et al. Computer-assisted prescribing of kanamycin for patients with renal insufficiency. , 1972, Lancet.
[89] R W Jelliffe,et al. Estimation of creatinine clearance when urine cannot be collected. , 1971, Lancet.
[90] H. M. Whyte,et al. Plasma creatinine level and creatinine clearance as tests of renal function. , 1959, Australasian annals of medicine.
[91] G. Navis,et al. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. , 2004, Kidney international.
[92] T. Larson,et al. Measured and estimated GFR in healthy potential kidney donors. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[93] T. Dwyer,et al. Is obesity a major cause of chronic kidney disease? , 2004, Advances in renal replacement therapy.
[94] T. Lüscher,et al. Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. , 2000, Hypertension.
[95] L. Landsberg. Insulin resistance, energy balance and sympathetic nervous system activity. , 1990, Clinical and experimental hypertension. Part A, Theory and practice.
[96] B. Kasiske,et al. Effects of genetic obesity on renal structure and function in the Zucker rat. II. Micropuncture studies. , 1985, The Journal of laboratory and clinical medicine.
[97] B. Kasiske,et al. Glomerular sclerosis in patients with massive obesity. , 1985, American journal of nephrology.
[98] B. Brenner,et al. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. , 1983, Kidney international.
[99] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .